1. 290 Development and first-in-human characterization of an ICOSL and BAFF bispecific inhibitor AMG 570 for SLE treatment. (April 2019) Authors: Cheng, Laurence E; Hsu, Hailing; Kankam, Martin; Siebers, Nicholas; Stoltz, Randall; Abuqayyas, Lubna; Ertik, Bella; Sullivan, Barbara; Zhou, Lei; Parnes, Jane R Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P132 Design of an adaptive, phase 2, placebo-controlled, dose-ranging study to assess the efficacy and safety of AMG 570 in subjects with active SLE and inadequate response to standard of care therapy. (23rd March 2020) Authors: Zhou, Lei; Wang, Hui; Jiang, Tony; Garces, Sandra; Cheng, Laurence E; Lenz, Rob; Kaur, Primal Journal: Lupus science & medicine Issue: Volume 7(2020)Supplement 1 Page Start: A93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗